Open-source LLMs for pharma & life sciences
Pharma teams use open models for literature review, regulatory writing, pharmacovigilance case processing and lab-protocol assistance under GxP controls.
Where pharma & life sciences teams use language models
- Literature review & evidence synthesislow risk
Summarise papers, extract endpoints
- Regulatory document draftinghigh risk
CTD sections, responses to agency queries
- Pharmacovigilance case intakehigh risk
Extract adverse-event data from reports and emails
- Medical-information response draftingmedium risk
Answer HCP enquiries from approved content
- Clinical-trial protocol assistancemedium risk
Draft and check protocol sections
- SOP & GxP document searchlow risk
Find and explain procedures
- Lab notebook & protocol assistantlow risk
Summarise experiments, suggest next steps
- Promotional-material compliance reviewmedium risk
Flag claims that need substantiation
- Bioinformatics code assistancelow risk
Pipelines, analysis scripts
Validated environments and GxP records shape this playbook: it asks which outputs become regulated records and whether the system needs computer-system validation.
Frequently asked
Does using an LLM for regulatory writing require validation?
If outputs become GxP records, yes: treat the deployment as a computerised system, document intended use, run validation and keep human approval and full audit logs.